e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Genetics of airway diseases and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Genetic analysis of two novel mucin-like genes in the disease-susceptibility locus for diffuse panbronchiolitis
M. Hijikata, I. Matsushita, H. Ito, J. Ohashi, S. Homma, Y. Taguchi, A. Azuma, S. Kudoh, N. Keicho (Tokyo, Ibaraki, Nara, Japan)
Source:
Annual Congress 2011 - Genetics of airway diseases and treatment
Session:
Genetics of airway diseases and treatment
Session type:
Poster Discussion
Number:
447
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Hijikata, I. Matsushita, H. Ito, J. Ohashi, S. Homma, Y. Taguchi, A. Azuma, S. Kudoh, N. Keicho (Tokyo, Ibaraki, Nara, Japan). Genetic analysis of two novel mucin-like genes in the disease-susceptibility locus for diffuse panbronchiolitis. Eur Respir J 2011; 38: Suppl. 55, 447
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Positional cloning on 19q13 identifies
UPAR
as a potential asthma susceptibility gene
Source: Eur Respir J 2007; 30: Suppl. 51, 37s
Year: 2007
Human exome analysis of candidate genetic variants for susceptibility to high-altitude pulmonary edema in Japanese
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020
Identification and analysis of rare and novel mutations of the alpha-1-antitrypsin gene
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
An informative intragenic microsatellite marker suggests the IL-1 receptor as a genetic modifier in cystic fibrosis
Source: Eur Respir J, 50 (6) 1700426; 10.1183/13993003.00426-2017
Year: 2017
Susceptibility genes for lung diseases in the major histocompatibility complex revealed by lung expression quantitative trait loci analysis
Source: Eur Respir J 2016; 48: 573-576
Year: 2016
Identification of multiple asthma susceptibility loci within the
lmr1
locus on mouse chromosome 17
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010
Is the BTNL2 genotype associated with specific HLA-DRB1 and DRB3/4/5 alleles in Danish sarcoidosis patients?
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015
Disease modifier genes in cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=50
Year: 2006
Association between BTNL2 and sarcoidosis evolution is secondary to HLA-DRB1* alleles
Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases
Year: 2009
Linkage and haplotype analyses for chemokine receptors clustered in chromosome 3q21.3 in family pedigrees with asthma and atopy
Source: Eur Respir J 2004; 24: Suppl. 48, 135s
Year: 2004
Genome-wide association analysis reveals 12q13.3–q14.1 as new risk locus for sarcoidosis
Source: Eur Respir J 2013; 41: 888-900
Year: 2013
A genetic landscape of familial predisposition to sarcoidosis identified by whole exome sequencing
Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways
Year: 2017
Evaluation of ANXA11 rs1049550 SNP linkage with sarcoidosis susceptibility
Source: Annual Congress 2012 - Sarcoidosis
Year: 2012
Identification of novel rare genetic variants associated with COPD in the general population
Source: International Congress 2018 – Multiomics studies in epidemiology: what can they tell us?
Year: 2018
Human genetic variability and susceptibility to pulmonary TB
Source: Eur Respir Mon 2012; 58: 38-58
Year: 2012
Investigating the role of IREB2 genetic variants in susceptibility to COPD
Source: Annual Congress 2012 - Gene-environment treatment and asthma
Year: 2012
Large phenotypic spectrum associated with two new deep intronic variants on the CFTR gene
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Homozygous variant rs2076530 of BTNL2 and familial sarcoidosis: analysis of 5 members of a family
Source: Annual Congress 2007 - Novel genetic markers in pathology
Year: 2007
Polymorphism and copy number variation of FCGR genes in an etiopathogenesis of sarcoidosis
Source: International Congress 2016 – Sarcoidosis
Year: 2016
Genetic polymorphism of
FOXP3
gene in sarcoidosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept